Salgs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Salgs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Salgs Today - Breaking & Trending Today

Short Interest in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Increases By 6.4%

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 894,500 shares, a growth of 6.4% from the January 15th total of 840,400 shares. Based on an average daily volume of 294,500 shares, […] ....

Topco Ltd , Prelude Capital Management , Mirabella Financial Services , Charles Schwab Investment Management Inc , Aligos Therapeutics Inc , Aligos Therapeutics , Get Free Report , Capital Management , Schwab Investment Management , Financial Services , Aligos Therapeutics Daily , Nasdaq Algs ,

Critical Analysis: Aligos Therapeutics (NASDAQ:ALGS) versus INmune Bio (NASDAQ:INMB)

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) and INmune Bio (NASDAQ:INMB – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Risk and Volatility Aligos Therapeutics has a […] ....

United States , South San Francisco , Boca Raton , Inmune Bio , Katholieke Universiteit Leuven , Emory University , Aligos Therapeutics Inc , Inmune Bio Inc , Luxna Biotech Co Ltd , Xiamen Amoytop Biotech Co Ltd , University Of Pittsburg , Xencor Inc , Aligos Therapeutics , Get Free Report , Treatment Resistant , Immune Ventures , Aligos Therapeutics Daily , Nasdaq Algs , Stock Comparison , Stock Analysis ,

Aligos Therapeutics (NASDAQ:ALGS) versus INmune Bio (NASDAQ:INMB) Financial Contrast

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) and INmune Bio (NASDAQ:INMB – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability. Volatility and Risk Aligos Therapeutics has a […] ....

Boca Raton , United States , South San Francisco , Katholieke Universiteit Leuven , Inmune Bio , Xencor Inc , University Of Pittsburg , Xiamen Amoytop Biotech Co Ltd , Luxna Biotech Co Ltd , Inmune Bio Inc , Aligos Therapeutics Inc , Emory University , Aligos Therapeutics , Get Free Report , Treatment Resistant , Immune Ventures , Aligos Therapeutics Daily , Nasdaq Algs , Stock Comparison , Stock Analysis ,

Odevixibat Maintains Alagille Syndrome Pruritus, Bile Acid Reductions at 36 Weeks

New pooled phase 3 and extension trial data show odevixibat continues to improve disease management and itch reduction in children with Alagille syndrome. ....

United States , Mercy Hospital , Odevixibat Bylvay , Ryant Fischer , Drug Administration , Liver Meeting , American Association , Liver Diseases , Mercy Kansas City , Alagille Syndrome , Bile Acid ,